Timed to the travel and corresponding cold and flu season, Treato, a leading consumer healthcare website, announced its first annual list of top over-the-counter (OTC) cough medications. This list is the first in a new series of drug rankings from the company. According to the Consumer Healthcare Products Association, the internal analgesics (pain reliever/ fever reducer) category is highly profitable, taking in more than $3.8 billion over the past year. Rickitt Benckiser's Mucinex brands dominate the list with their formulations taking three of the top four spots. Mucinex D took the number one spot, Mucinex took the third spot and Mucinex DM took the fourth spot on the list.
Dilip Shanghvi-led Sun PharmaBSE 1.55 % has bid to acquire US-based eye care company InSite Vision Inc., as its expands its basket of specialty products to boost sales. The deal may be valued at around Rs. 300 crore representing $0.35 per share for each InSite Vision share on the local US OTC stock exchange. InSite's 2014 full year revenues stood at close to Rs. 55 crore.
Market Place
Share